Clinical Features of COPD Flashcards

(47 cards)

1
Q

COPD definition

A

Lung disease characterised by chronic obstruction of lung airflow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diseases included within COPD

A

Chronic bronchitis

Emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

COPD symptoms are due to

A

Airway and/or alveolar abnormalities caused by significant exposure to noxious particles or gases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Risk factors of COPD

A
Smoking (no.1)
Occupation
Age
Lower socioeconomic status
Asthma/airway hyper-reactivity
Childhood infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Is COPD more common in men or women

A

Women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Alpha-1 antitrypsin

A

Protease inhibitor made in the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Function of alpha-1 antitrypsin

A

Limits damage caused by activated neutrophils releasing elastase in response to infection/cigarette smoke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Effect of alpha-1 antitrypsin deficiency

A

Alveolar damage and emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Percentage of smokers that develop COPD

A

<50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Common symptoms of COPD

A
Shortness of breath
Recurrent chest infections
Ongoing cough
Sputum
Wheeze
Chest tightness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Less common symptoms of COPD

A
Weight loss
Fatigue
Decreased exercise tolerance
Ankle swelling (heart failure)
Cor pulmonale
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Examination findings in COPD

A
Cyanosis
Raised JVP
Cachexia
Wheeze
Pursed lip breathing
Hyper-inflated chest
Use of accessory muscles
Peripheral oedema
Flapping tremor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

mMRC breathlessness scale

A

0-4, 0 being breathlessness with strenuous exercise, 4 being too breathless to leave the house

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Diagnosis criteria

A
Typical symptoms
Aged > 35
Presence of risk factor
Absence of clinical features of asthma
Airflow obstruction confirmed by spirometry
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Spirometry of stage 1 COPD

A

80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Spirometry of stage 2 COPD

A

50-79%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Spirometry of stage 3 COPD

A

30-49%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Spirometry of stage 4 COPD

A

<30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Spirometry demonstrates

A

Lack of reversibility

20
Q

Spirometry in restrictive disorder

A

Ratio is normal as both FEV1 and FVC reduced

21
Q

Signs on chest x-ray of COPD

A
Vascular hila
Hyperinflation
Bulla
Small heart
Flat diaphragm
22
Q

How many people are living with COPD in the UK

A

1.2 million (2% pop)

23
Q

How common is COPD out of all lung diseases

A

2nd most common

24
Q

Is the prevalence of COPD increasing or decreasing

25
How many people are diagnosed with COPD each year in the UK
115,000
26
Are incidences of COPD increasing or decreasing
Decreasing
27
Onset of COPD compared to asthma
In mid-life whereas asthma in early life
28
Progressiveness of symptoms of COPD
Slowly progressive
29
People with COPD usually have a history of
Tobacco smoking or exposure to other types of smoke
30
If unsure if asthma or COPD, carry out
Pulmonary function tests - lung volumes and transfer factor
31
Residual volume in COPD
Increases
32
Total lung capacity in COPD
Increases
33
RV/TLC
>30%
34
Gas transfer in COPD
Reduces
35
Diffusion of carbon monoxide in COPD
Decreases
36
Carbon monoxide transfer coefficient abundance in COPD
Decreases
37
Radiology to differentiate between COPD and asthma
High resolution computed tomography (HRCT)
38
Differential finding in HRCT in COPD
Upper zone emphysema
39
2 main things that differentiate COPD and asthma
Diurnal variability and reversibility with bronchodilators
40
Management of acute exacerbations in primary care
Change in inhalers Oral steroids (prednisolone) Antibiotics
41
Acute exacerbation in secondary care triggers
Viral/bacterial infection Sedative drugs Trauma
42
Treatment of acute exacerbations in secondary care
Oxygen Nebulised bronchodilator Oral/IV corticosteroids Antibiotics
43
Factors used to measure severity
Spirometry Nature and magnitude of symptoms History of moderate and severe exacerbations and future risk Presence of co-morbidity
44
How much does NHS spend on prescribed inhalers each year
£10 million
45
Number of deaths from COPD worldwide annually
3 million
46
Predicated COPD related deaths worldwide annually in 2030
4.5 million
47
Number on thing patients can do to slow progression of COPD
Stop smoking